Blog

Eytan Ruppin: The first AI to discover spatial biomarkers for cancer treatment

Photo taken from Eytan Ruppin/X

Oct 21, 2024, 13:57

Eytan Ruppin: The first AI to discover spatial biomarkers for cancer treatment

Eytan Ruppin, Chief of the Cancer Data Science Laboratory, shared on X:

”Proud to launch Path to Space — the first AI to discover spatial biomarkers for cancer treatment! It predicts spatial gene expression from histopathology, enabling large-scale tumor microenvironment profiling.”

Path2Space: An AI Approach for Cancer Biomarker Discovery Via Histopathology Inferred Spatial Transcriptomics

Authors: Eldad David Shulman, Emma M Campagnolo, Roshan Lodha, Thomas Cantore, Tom Hu, Maclean Nasrallah, Danh-Tai Hoang, Kenneth Aldape, Eytan Ruppin.

biomarkers for cancer treatment cancer Danh-Tai Hoang Eldad David Shulman Emma M Campagnolo Eytan Ruppin histopathology Kenneth Aldape Maclean Nasrallah OncoDaily Oncology Path to Space Roshan Lodha Thomas Cantore Tom Hu tumor microenvironment profiling

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage